About the journal
American Heart Journal Plus is an open-access journal published by Elsevier in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,950 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier
- ISSN
- 2666-6022
- Country
- United States
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,950 USD
- Articles in DOAJ
- 770
- Declared review time
- 16 weeks
- Declared peer-review model
- other
Index listings
- DOAJ · 2022-02-21
- Indexing
- DOAJ
- APC
- 2,950 USD
- Declared review time (DOAJ)
- 16 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
770
Most recent article
last month
Average review time (journal-declared via DOAJ)
16weeks
Works in OpenAlex
788
Last recorded publication year
2026
h-index
22
i10-index
67
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-04-27
- Added to DOAJ
- 2022-02-21
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 8%
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity3
- Alternate titles
- AHJ plus
- Source type
- journal
- NLM unique ID (PubMed)
- 101779333
Classification2
Subjects (DOAJ)
LCC codes
Subject areas
- Heart Failure Treatment and Management
- Cardiac Imaging and Diagnostics
- Cardiac Imaging and Diagnostics
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Acute Myocardial Infarction Research
- Acute Myocardial Infarction Research
- Coronary Interventions and Diagnostics
Show all subjects (75)
- Heart Failure Treatment and Management
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Cardiovascular Function and Risk Factors
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Atrial Fibrillation Management and Outcomes
- Coronary Interventions and Diagnostics
- Coronary Interventions and Diagnostics
- Cardiac Health and Mental Health
- Mechanical Circulatory Support Devices
- Mechanical Circulatory Support Devices
- Cardiac Valve Diseases and Treatments
- Mechanical Circulatory Support Devices
- COVID-19 Clinical Research Studies
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiac Health and Mental Health
- Cardiovascular Health and Risk Factors
- Cardiac Health and Mental Health
- Cardiac Structural Anomalies and Repair
- Cardiac Valve Diseases and Treatments
- Cardiac Structural Anomalies and Repair
- Cardiac Valve Diseases and Treatments
- Cardiac electrophysiology and arrhythmias
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- Cardiac pacing and defibrillation studies
- Cardiac Arrhythmias and Treatments
- Chemotherapy-induced cardiotoxicity and mitigation
- Takotsubo Cardiomyopathy and Associated Phenomena
- Cardiac Arrhythmias and Treatments
- Chemotherapy-induced cardiotoxicity and mitigation
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac pacing and defibrillation studies
- Cardiac tumors and thrombi
- Cardiovascular Health and Risk Factors
- Cardiovascular Health and Risk Factors
- Chemotherapy-induced cardiotoxicity and mitigation
- Aortic Disease and Treatment Approaches
- Cardiac pacing and defibrillation studies
- Blood Pressure and Hypertension Studies
- Sex and Gender in Healthcare
- Lipoproteins and Cardiovascular Health
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Cardiovascular Disease and Adiposity
- ECG Monitoring and Analysis
- Cardiovascular Disease and Adiposity
- Lipoproteins and Cardiovascular Health
- Cardiovascular Issues in Pregnancy
- Diabetes Treatment and Management
- Cardiomyopathy and Myosin Studies
- Diabetes Treatment and Management
- Venous Thromboembolism Diagnosis and Management
- Pericarditis and Cardiac Tamponade
- Cardiovascular Issues in Pregnancy
- Pericarditis and Cardiac Tamponade
- Adipokines, Inflammation, and Metabolic Diseases
- Cardiac, Anesthesia and Surgical Outcomes
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Adipokines, Inflammation, and Metabolic Diseases
- Blood Pressure and Hypertension Studies
- Blood Pressure and Hypertension Studies
- Cardiac electrophysiology and arrhythmias
- Cardiac electrophysiology and arrhythmias
- Sepsis Diagnosis and Treatment
Keywords (DOAJ)
- clinical cardiology
- experimental cardiology
- coronary artery disease
- prevention and rehabilitation
- interventional cardiology
- women’s issues in cardiology
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ